{"id":"ncardipine-hydrochloride-injection","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Flushing"},{"rate":null,"effect":"Tachycardia"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Hypotension"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Nicardipine selectively blocks L-type calcium channels in vascular smooth muscle, preventing calcium-dependent contraction and leading to peripheral vasodilation. This results in reduced systemic vascular resistance and blood pressure lowering. The intravenous formulation provides rapid onset of action suitable for acute hypertensive episodes.","oneSentence":"Nicardipine hydrochloride is a dihydropyridine calcium channel blocker that inhibits calcium influx into vascular smooth muscle cells, causing vasodilation and reducing blood pressure.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:50:22.014Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute hypertension management"},{"name":"Hypertensive emergency"}]},"trialDetails":[{"nctId":"NCT04670809","phase":"PHASE3","title":"Safety and Efficacy Study of Clevidipine Butyrate Injection in Hypertensive Emergencies","status":"UNKNOWN","sponsor":"Nanjing Yoko Biomedical Co., Ltd.","startDate":"2020-07-27","conditions":"Hypertensive Emergency","enrollment":262}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":331,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Ncardipine Hydrochloride Injection","genericName":"Ncardipine Hydrochloride Injection","companyName":"Nanjing Yoko Biomedical Co., Ltd.","companyId":"nanjing-yoko-biomedical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Nicardipine hydrochloride is a dihydropyridine calcium channel blocker that inhibits calcium influx into vascular smooth muscle cells, causing vasodilation and reducing blood pressure. Used for Acute hypertension management, Hypertensive emergency.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}